Company Description
Vg Life Sciences (OTC Link: VGLS) is a publicly traded real estate - development company in the Real Estate sector. The company has a market capitalization of $2.1M.
VGLS stock has gained 0.0% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, Vg Life Sciences reported revenue of $0 with net income of -$6.2M.
This page provides a comprehensive overview of VGLS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vg Life Sciences (VGLS) stock last traded at $0.0001. At a market capitalization of $2.1M, VGLS is classified as a micro-cap stock with approximately 21.1B shares outstanding.
Latest News
SEC Filings
Vg Life Sciences has filed 1 recent SEC filing, including 1 Form 10-12G. The most recent filing was submitted on March 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VGLS SEC filings →
Financial Highlights
operating income reached -$4.1M, and net income was -$6.2M. The company generated -$1.9M in operating cash flow. With a current ratio of 0.04, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
VGLS Company Profile & Sector Positioning
Vg Life Sciences (VGLS) operates in the Real Estate - Development industry within the broader Real Estate sector and is listed on the OTC Link.